Psychotherapeutic Drugs and Biogenic Amines Current Concepts and Therapeutic Implications
- 1 August 1984
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 28 (2) , 127-143
- https://doi.org/10.2165/00003495-198428020-00003
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Yohimbine induced anxiety and increased noradrenergic function in humans: Effects of diazepam and clonidineLife Sciences, 1983
- Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatmentNature, 1980
- Reduced brain monoamine synthesis by systemic treatment with terbutaline, a ?2-receptor agonistJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980
- Demonstration of specific “high affinity” binding sites for [3H] imipramine on human plateletsLife Sciences, 1980
- The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonistsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979
- Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depressionPsychopharmacology, 1977
- Use of plasma norepinephrine for evaluation of sympathetic neuronal function in manLife Sciences, 1976
- Measurement of the two conjugates of 3-methoxy-4-hydroxyphenylglycol in urineBiochemical Medicine, 1974
- 3-Methoxy-4-hydroxyphenylglycol in depressionPsychological Medicine, 1973
- INTENSIFICATION OF THE CENTRAL SEROTONINERGIC PROCESSES AS A POSSIBLE DETERMINANT OF THE THYMOLEPTIC EFFECTPublished by Elsevier ,1969